Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAID: Ranolazine in High-Risk ICD Patients
NCT01215253Phase 3Completed
- Sponsor
- University of Rochester
- Start
- Sep 2011
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in ventricular arrhythmia (VA) comparing Ranolazine with Placebo (2 arms). Primary endpoint: Number of Patients With Ventricular Tachycardia (VT) or Ventricular Fibrillation (VF) or Death at 2 years. Started Sep 2011; status: completed.
02
Drugs
ranolazine
03
Conditions
ventricular arrhythmia (VA)
Beyond the preview
Go deeper on NCT01215253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01215253.